The Life Sciences & Healthcare industry is at a fantastic period with unprecedented improvement of health thanks to innovation. Products are developed under market forces. But as the Covid-19 pandemic demonstrates, when there is an urgent, public health need authorities have to intervene to ensure sufficient financing and reduce commercial risk to the companies. Covid-19 […]
Life Science
Pandemic Highlights Need for Cooperation
Cornerstone Ramps up Pharma Practice in India
The Life Sciences and Healthcare practice of Cornerstone International Group is gearing up for increased activity in India. Within only a few months of its formation, the team in India has added three senior level executive search resources effective January 1, 2017. India’s pharmaceutical market is the world’s third largest in volume and the largest […]
China’s Next $100B Market
China today is gearing up for an explosion in the development of private healthcare that is expected to exceed US $100 billion by 2030.
Managing Asia Series: Growth Forecasting Turns to Domestic Demand
Cornerstone China’s new Life Sciences & Healthcare practice provides a window on the new forces shaping the Chinese economy. Will 2016 be a year of continued Growth or a year of Consolidation in China!? President Xi Jiping and Premier Li Keqian have stated that China is in the midst of an economic transformation from a […]